Europe endometrial ablation market was valued at $514.8 million in 2022 and will grow by 3.7% annually over 2022-2032, driven by the huge prevalence of Gynecological disorders and growing cases of cervical cancer, emergence of next generation ablation procedures and minimally invasive surgical techniques, the benefits of Endometrial Ablation over Hysterectomy (surgical removal of the uterus), growing adoption of ablation procedures, and the government initiatives for the development of the healthcare sector.

Highlighted with 22 tables and 34 figures, this 83-page report “Europe Endometrial Ablation Market 2022-2032 by Offering (Devices, Procedures), Technology (Radiofrequency, Cryoablation, Hydrothermal, Thermal Balloon, Hysteroscopic, Microwave Energy, Electrical), End User (Hospitals, Clinics, ASCs), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe endometrial ablation market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe endometrial ablation market in every aspect of the classification from perspectives of Offering, Technology, End User, and Country.

Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Devices
  • Procedures


Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Radiofrequency Ablation
  • Cryoablation
  • Hydrothermal Ablation
  • Thermal Balloon
  • Hysteroscopic Ablation
  • Microwave Energy
  • Electrical Ablators


By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers (ASCs)


Geographically, the following national/local markets are fully investigated:

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)


For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Offering, Technology and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

  • AngioDynamics Inc.
  • Boston Scientific Corporation
  • Cooper Surgical Inc.
  • Ethicon, Inc. (Johnson & Johnson)
  • Hologic, Inc.
  • Karl Storz GmbH & Co. KG
  • Medtronic Plc
  • Minerva Surgical, Inc.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith & Nephew Plc

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)